These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10784232)

  • 21. Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243.
    Kobayashi T; Oka Y; Katagiri H; Falorni A; Kasuga A; Takei I; Nakanishi K; Murase T; Kosaka K; Lernmark A
    Diabetologia; 1996 Oct; 39(10):1196-200. PubMed ID: 8897007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latent autoimmune diabetes in Tunisian adults (LADA): identification of autoimmune markers.
    Amrouche Ch; Jamoussi Kamoun H; Trabelsi N; Blouza Chabchoub S
    Tunis Med; 2008 Apr; 86(4):316-8. PubMed ID: 19476130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD-negative patients with type 1 and type 2 diabetes mellitus.
    Bárová H; Perusicová J; Hill M; Sterzl I; Vondra K; Masek Z
    Physiol Res; 2004; 53(3):279-86. PubMed ID: 15209535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GAD65 antibodies in classification of Asian Indian diabetic subjects with onset between 20 and 40 years.
    Ramachandran A; Snehalatha C; Satyavani K; Sivasankari S; Vijay V
    Diabetes Care; 1999 Jan; 22(1):175-6. PubMed ID: 10333923
    [No Abstract]   [Full Text] [Related]  

  • 25. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression.
    Velloso LA; Kämpe O; Hallberg A; Christmanson L; Betsholtz C; Karlsson FA
    J Clin Invest; 1993 May; 91(5):2084-90. PubMed ID: 8486775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
    Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate and its effect on the anti-GAD titre in two patients with rheumatoid arthritis and diabetes mellitus.
    van Deutekom AW; Nurmohamed MT; Peters MJ; van Eijk IC; Dijkmans BA; Hamann D; Heine RJ; Simsek S
    Ann Rheum Dis; 2008 Jul; 67(7):1051-2. PubMed ID: 18556448
    [No Abstract]   [Full Text] [Related]  

  • 28. Antibodies to GAD in elderly patients with previously diagnosed NIDDM.
    Fukui M; Nakamura N; Nakano K; Sawada M; Aoji O; Obayashi H; Shigeta H; Kondo M
    Diabetes Care; 1998 Apr; 21(4):675-6. PubMed ID: 9571369
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anti glutamic acid decarboxylase (GAD) antibody].
    Yamanouchi T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():594-6. PubMed ID: 20960836
    [No Abstract]   [Full Text] [Related]  

  • 30. GAD antigen and its significance in type I diabetes.
    Hawa MI; Leslie RD
    J Endocrinol Invest; 2002; 25(7):576. PubMed ID: 12150328
    [No Abstract]   [Full Text] [Related]  

  • 31. Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β-cell function in women with gestational diabetes mellitus.
    Lundberg TP; Højlund K; Snogdal LS; Jensen DM
    Diabet Med; 2015 Feb; 32(2):198-205. PubMed ID: 25345799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of GAD autoantibodies in Brazilian women with previous gestational diabetes.
    Ferraz TB; Motta RS; Capibaribe DM; Ferraz CL; Chacra AR; Forti AC; Dib SA
    Diabetes Res Clin Pract; 2007 Oct; 78(1):141-2. PubMed ID: 17367891
    [No Abstract]   [Full Text] [Related]  

  • 33. [The glutamic acid decarboxylase (GAD) antibodies and their clinical significance].
    Ogata K; Ohta K; Kubo H; Yamaguchi A; Watanabe H
    Rinsho Byori; 1995 May; 43(5):468-71. PubMed ID: 7783365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to GAD in chronic hepatitis C patients.
    Hiéronimus S; Fredenrich A; Tran A; Benzaken S; Fénichel P
    Diabetes Care; 1997 Jun; 20(6):1044. PubMed ID: 9167125
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti glutamate-decarboxylase antibodies: a liaison between localisation related epilepsy, stiff-person syndrome and type-1 diabetes mellitus.
    Szűcs A; Barcs G; Winkler G; Soós Z; Folyovich A; Kelemen A; Várallyay P; Kamondi A
    Ideggyogy Sz; 2014 Jul; 67(7-8):269-71. PubMed ID: 25509368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Early diagnosis of diabetes mellitus with the anti-GAD test].
    Jungmann E
    Fortschr Med; 1994 Dec; 112(35-36):8-9. PubMed ID: 7843686
    [No Abstract]   [Full Text] [Related]  

  • 37. [Autoantibodies against GAD and GAD65].
    Tsujii S
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():190-5. PubMed ID: 9513413
    [No Abstract]   [Full Text] [Related]  

  • 38. [Autoantibodies against GAD, GAD65 and IA-2].
    Tsujii S
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():395-400. PubMed ID: 12355780
    [No Abstract]   [Full Text] [Related]  

  • 39. [Autoantibodies to glutamate decarboxylase in children with newly detected insulin-dependent diabetes mellitus].
    Trofimenko EV; Zlobina EV; Lebedev NV; Martynova MI; Piliutik VF; Shchegol'kova TS; Zlobina EN; Dedov II
    Probl Endokrinol (Mosk); 1994; 40(2):18-21. PubMed ID: 8197083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [GAD antibodies, GAD65 antibody].
    Yamanouchi T
    Nihon Rinsho; 1999 Dec; 57 Suppl():372-5. PubMed ID: 10778142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.